Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announces that its Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the 2023 Annual General Meeting (“AGM”) are now available on the Company’s website at www.avacta.com/investors/documents.
Copies of the Annual Report and Accounts and the Notice of the AGM have been posted to registered shareholders who have elected to receive them in paper form.
The Annual General Meeting will be held on Wednesday, 28 June 2023 at 10.30 a.m. BST at The Royal Society of Medicine, 1 Wimpole Street, Westminster, London W1G 0AE (the “Venue”).
The Venue has a capacity of approximately 140 people. Registered shareholders have a right to attend the AGM. In addition, the current expectation is that the chair of the AGM will, at their discretion, permit beneficial shareholders to attend in person. Shareholders (registered or beneficial) who propose to attend the AGM in person are requested to pre-register their interest and, to assist the Company in its preparation for the AGM, prove their shareholding by emailing FTI Consulting at avacta.ls@fticonsulting.com by 10:30 a.m. BST on 27 June 2023. Any failure to pre-register will not, of itself, preclude a registered shareholder from attending the AGM in person (or by proxy).
Only registered shareholders who attend in person or by proxy will be able to vote on the day. Details of how to submit a proxy vote are contained in the Notice of the AGM.
The Company will provide a business update following the AGM, which will be streamed live on the Investor Meet Company platform. Investors who already follow Avacta on Investor Meet Company will automatically be invited to join the live stream. Investors who do not have an Investor Meet Company account can sign up for free via the following link https://www.investormeetcompany.com/avacta-group-plc/register-investor and then click “Add to meet” Avacta Group in order to receive an invitation for the live stream. Those attending in person will be able to meet with a range of Avacta staff, view recently presented data posters and hear additional technical presentations.
Early pre-registration to attend the AGM in person is recommended as the Venue’s capacity is limited (as referred to above) and, for non-registered shareholders, registrations will be dealt with on a first come, first served basis.
All presentation materials will be made available on the website at the end of the day and no new material information will be provided.